Agenus, Inc. (AGEN)
4.675
+0.06
(+1.41%)
USD |
NASDAQ |
Jan 14, 16:00
4.70
+0.02
(+0.53%)
After-Hours: 20:00
Agenus EPS Diluted (Quarterly): 1.944 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.8721 |
| Cardiff Oncology, Inc. | -0.1684 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
| Bionano Genomics, Inc. | -1.593 |
| Twist Bioscience Corp. | -0.4491 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 63.91M |
| Revenue (Quarterly) | 30.24M |
| Total Expenses (Quarterly) | -33.68M |
| Enterprise Value | 487.53M |
| Gross Profit Margin (Quarterly) | 87.85% |
| Earnings Yield | -45.51% |
| Normalized Earnings Yield | -92.07 |